Neonatal diabetes mellitus due to a novel variant in the INS gene

Neonatal diabetes mellitus (NDM) is a rare condition that presents with diabetes in the first few months of life. The treatment of NDM may differ depending on the genetic etiology, with numerous studies showing the benefit of sulfonylurea therapy in cases caused by mutations in KCNJ11 or ABCC8. Mutations in the insulin gene (INS) have also been identified as causes of NDM; these cases are generally best treated with insulin alone. We report a case of a female infant born small for gestational age (SGA) at late preterm diagnosed with NDM at 7 wk of life who was found by rapid whole-genome sequencing to harbor a novel de novo c.26C>G (p.Pro9Arg) variant in the INS gene. She presented with diabetic ketoacidosis, which responded to insulin therapy. She did not respond to empiric trial of sulfonylurea therapy early in her hospital course, and it was discontinued once a genetic diagnosis was made. Early genetic evaluation in patients presenting with NDM is essential to optimize therapeutic decision-making.

[1]  H. Huopio,et al.  Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes , 2018, eLife.

[2]  S. Kingsmore,et al.  Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization , 2018, npj Genomic Medicine.

[3]  S. Ellard,et al.  Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation , 2018, Journal of pediatric endocrinology & metabolism : JPEM.

[4]  S. Jellimann,et al.  Neonatal diabetes mellitus: improved screening and early management of an underestimated disease , 2017, Clinical case reports.

[5]  A. Hattersley,et al.  The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study , 2015, The Lancet.

[6]  Hui Yang,et al.  Phenolyzer: phenotype-based prioritization of candidate genes for human diseases , 2015, Nature Methods.

[7]  P. Arvan,et al.  INS-gene mutations: from genetics and beta cell biology to clinical disease. , 2015, Molecular aspects of medicine.

[8]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[9]  M. Koga,et al.  Glycemic control indicators in patients with neonatal diabetes mellitus. , 2014, World journal of diabetes.

[10]  J. Støy.  Mutations in the insulin gene (revision number 6) , 2014 .

[11]  H. Yoo,et al.  Insulin pump therapy in transient neonatal diabetes mellitus , 2013, Annals of pediatric endocrinology & metabolism.

[12]  A. Hattersley,et al.  Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study , 2012, Pediatric diabetes.

[13]  C. Nichols,et al.  Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births , 2011, Acta Diabetologica.

[14]  P. Arvan,et al.  Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth , 2010, Trends in Endocrinology & Metabolism.

[15]  B. Shields,et al.  Insulin Mutation Screening in 1,044 Patients With Diabetes , 2008, Diabetes.

[16]  Stephen O’Riordana,et al.  Insulin mutation screening in 1 , 044 patients with diabetes : mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood , 2008 .

[17]  M. Polak,et al.  Neonatal diabetes mellitus : a disease linked to multiple mechanisms , 2015 .

[18]  N. Tubiana-Rufi.  Insulin pump therapy in neonatal diabetes. , 2007, Endocrine development.

[19]  F. Ashcroft,et al.  Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. , 2006, The New England journal of medicine.

[20]  R. Scharfmann,et al.  Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. , 2006, The New England journal of medicine.

[21]  E. Araki,et al.  Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells , 2002, Apoptosis.

[22]  G. Erbaş,et al.  Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. , 1998, AJR. American journal of roentgenology.